Further discussion will concentrate on the effects of IL-6 in the invasion-metastasis cascade across a range of cancer types, showing the applicability of targeting both IL-6 signalling and tumour cell migration as a therapeutic goal in cancer treatment. The gene discussed is IL6; the disease is neoplasm.